GlassScriptPhysician profile
Bobby Huynh
NPI 1114035383
$2,915.38
in general payments reported to CMS, 2019-2025
20 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $444 · 2020: $56.15 · 2021: $241 · 2022: $225 · 2023: $251 · 2024: $1,576 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $1,485 · Food and Beverage: $464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $1,484.75 |
| Food and Beverage | $464.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $1,558.36 | 2019-2024 | Durolane |
| Abbvie INC. | $380.42 | 2022-2025 | |
| Scilex Pharmaceuticals INC. | $248.70 | 2019-2022 | |
| Merz North America, INC. | $162.93 | 2019 | |
| Vision Quest Industries INC. | $94.67 | 2022 | |
| Mdd US Operations, LLC | $72.46 | 2019-2021 | |
| Allergan, INC. | $71.27 | 2021 | |
| Depuy Synthes Sales INC. | $46.78 | 2019-2024 | Orthovisc, Monovisc |
| Avanos Medical | $44.44 | 2023-2024 | Trivisc Sodium Hyaluronate |
| Pfizer INC. | $43.59 | 2019-2021 | |
| Ipsen Biopharmaceuticals, INC | $32.33 | 2020-2023 | Dysport |
| Ossur Americas, INC. | $26.67 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $23.22 | 2022 | |
| Ferring Pharmaceuticals INC. | $22.16 | 2025 | Euflexxa |
| Si-Bone, INC. | $21.88 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $20.86 | 2021 | |
| Fidia Pharma USA INC. | $18.94 | 2023 | Hymovis, Triluron |
| Pacira Therapeutics, INC. | $13.72 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.98 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bobby Huynh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.